Asthma drug formoterol shows potential to reverse fatty liver disease in mice

MASH affects hundreds of millions worldwide and is a leading cause of liver transplantation and liver failure.

In the long tradition of medicine's most consequential accidents, researchers at the Medical University of South Carolina discovered while studying kidney disease that formoterol — an asthma drug prescribed for decades — may reverse fatty liver disease by restoring the energy-producing capacity of damaged cells. The finding arrives at a moment when MASH, a progressive liver condition tied to obesity and diabetes, affects hundreds of millions worldwide and remains largely without effective treatment. Human trials are now underway, carrying the quiet possibility that a familiar, inexpensive drug

Asthma drug formoterol shows potential to reverse fatty liver disease in mice

Cobertura Relacionada

Receba o Register no seu e-mail